메뉴 건너뛰기




Volumn 40, Issue 11, 2005, Pages 1706-1707

Lack of efficacy of voriconazole therapy in 2 patients with pulmonary fungus balls [6]

Author keywords

[No Author keywords available]

Indexed keywords

VORICONAZOLE;

EID: 19344372599     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/430176     Document Type: Letter
Times cited : (3)

References (9)
  • 1
    • 0036283440 scopus 로고    scopus 로고
    • The clinical spectrum of pulmonary aspergillosis
    • Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest 2002; 121:1988-99.
    • (2002) Chest , vol.121 , pp. 1988-1999
    • Soubani, A.O.1    Chandrasekar, P.H.2
  • 2
    • 0033801039 scopus 로고    scopus 로고
    • Practice guidelines for diseases caused by Aspergillus
    • Infectious Diseases Society of America
    • Stevens D, Kan V, Judson M, et al. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis 2000; 30:696-709.
    • (2000) Clin Infect Dis , vol.30 , pp. 696-709
    • Stevens, D.1    Kan, V.2    Judson, M.3
  • 3
    • 0035746819 scopus 로고    scopus 로고
    • Chronic forms of pulmonary aspergillosis
    • Denning DW. Chronic forms of pulmonary aspergillosis. Clin Microbiol Infect 2001; 7(Suppl 2):25-31.
    • (2001) Clin Microbiol Infect , vol.7 , Issue.2 SUPPL. , pp. 25-31
    • Denning, D.W.1
  • 4
    • 0035095296 scopus 로고    scopus 로고
    • In vitro fungiddal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi
    • Espinel-Ingroff A. In vitro fungiddal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J Clin Microbiol 2001; 39:954-8.
    • (2001) J Clin Microbiol , vol.39 , pp. 954-958
    • Espinel-Ingroff, A.1
  • 5
    • 0037043655 scopus 로고    scopus 로고
    • Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
    • Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347:408-15.
    • (2002) N Engl J Med , vol.347 , pp. 408-415
    • Herbrecht, R.1    Denning, D.W.2    Patterson, T.F.3
  • 6
    • 18744388858 scopus 로고    scopus 로고
    • An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis
    • Chow L, Brown NE, Kunimoto D. An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis. Clin Infect Dis 2002; 35:e106-10.
    • (2002) Clin Infect Dis , vol.35
    • Chow, L.1    Brown, N.E.2    Kunimoto, D.3
  • 8
    • 0242509101 scopus 로고    scopus 로고
    • Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi
    • Rodríguez-Tudela JL, Chryssanthou E, Petrikkou E, et al. Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi. J Clin Microbiol 2003; 41:5236-7.
    • (2003) J Clin Microbiol , vol.41 , pp. 5236-5237
    • Rodríguez-Tudela, J.L.1    Chryssanthou, E.2    Petrikkou, E.3
  • 9
    • 0033848786 scopus 로고    scopus 로고
    • Voriconazole: A new triazole antifungal
    • Sabo JA, Abdel-Rahman SM. Voriconazole: a new triazole antifungal. Ann Pharmacother 2000; 34:1032-43.
    • (2000) Ann Pharmacother , vol.34 , pp. 1032-1043
    • Sabo, J.A.1    Abdel-Rahman, S.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.